# Study to Assess the Pharmacodynamics/Pharmacokinetics After Repeated Dosing of D961H 10 mg and Omeprazole 10 mg in Japanese Healthy Male Subjects

> **NCT01159145** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 42 (estimated)

## Conditions studied

- Pharmacodynamics Study

## Interventions

- **DRUG:** D961H
- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT01159145
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2010-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01159145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01159145, "Study to Assess the Pharmacodynamics/Pharmacokinetics After Repeated Dosing of D961H 10 mg and Omeprazole 10 mg in Japanese Healthy Male Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01159145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*